RankingsPricing
  1. JP-listed companies
  2. JCR Pharmaceuticals Co.,Ltd.
  3. Financials
  4. Earnings per share

JCR Pharmaceuticals Co.,Ltd.【JP:4552】

Market cap
¥91.7B
P/E ratio
29.2x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 2025-38.4-187.08%
Mar 31, 202444.1+45.40%
Mar 31, 202330.4-74.12%
Mar 31, 2022117.3+110.11%
Mar 31, 202155.8-35.77%
Mar 31, 202086.9-28.00%
Mar 31, 2019120.7+22.23%
Mar 31, 201898.7+67.48%
Mar 31, 201759+5.04%
Mar 31, 201656.1+6.19%
Mar 31, 201552.9+29.57%
Mar 31, 201440.8+77.12%
Mar 31, 201323+16.61%
Mar 31, 201219.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)